Navigation Links
Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis
Date:3/18/2013

to royalties. The compound has been tested in pre-clinical studies and the project is now entering the next phase - a phase 1 clinical trial in healthy human volunteers. After this trial has been completed, the plan is to do testing on psoriasis patients later this year. If the process proceeds as planned, the collaboration may result in an oral treatment for psoriasis in 6-7 years.

About Virobay, Inc.

Founded in 2006, Virobay is a leader in the design, synthesis and development of small molecule inhibitors of cysteine proteases, a class of enzymes that are key mediators in a variety of diseases, including autoimmunity, neuropathic pain, liver disease, cancer and cardiovascular disorders. Virobay's clinical pipeline currently includes product candidates in autoimmune disease, neuropathic pain and liver fibrosis. For more information, please visit http://www.virobayinc.com

About LEO Pharma

LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs approximately 5,000 people worldwide.

For more information, visit http://www.leo-pharma.com.


'/>"/>
SOURCE Virobay, Inc. and LEO Pharma A/S
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Educating, Informing, and Successfully Preparing the Marketplace for New Bio-Pharma Products
2. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
3. Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
4. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
5. Sagent Pharmaceuticals Selects ProspectoRx and Clinical Pharmacology
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
7. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
8. Salix Pharmaceuticals Commits $1.125M to AGA Research Foundation
9. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
10. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
11. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Calif., Oct. 21, 2014 Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis systems, today reported financial results for ... Second quarter overview: , Revenues of $53.9 ... , Diluted EPS of $0.24, up 33% over last ... Service revenues from Abaxis Veterinary Reference Laboratories (AVRL) of ...
(Date:10/22/2014)... Colo. , Oct. 22, 2014   Surefire ... of infusion systems designed to maximize targeted delivery of ... pleased to announce that oncologist John R. Daniels ... Comprehensive Cancer Center, and surgical oncologist Steven C. ... have joined the Company,s Scientific Advisory Board (SAB).    ...
(Date:10/22/2014)... Sanomedics International Holdings, Inc. (OTCQB: SIMH) – ... & Data Services, demand for thermometers is expected to ... as demand for more accurate digital thermometers continues.  ... largest market for thermometers, and one of the companies ... Holdings, Inc. Sanomedics International Holdings designs, develops, ...
Breaking Medicine Technology:Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2
... HARBIN, China , July 16 /PRNewswire-Asia-FirstCall/ ... or "the Company") (Nasdaq: CSKI ), a,leading fully ... Republic of China ("PRC"), today announced that Mr., ... Secretary, will be,unreachable by investors for a period of ...
... CHENGDU, China , July 16 /PRNewswire-Asia-FirstCall/ -- ... specializes in,patented biopharmaceutical, modernized traditional Chinese medicine and,branded generics provides ... , , ... The construction of the facility is on schedule, targeting ...
Cached Medicine Technology:China Sky One Medical's Chief Financial Officer's Health Issues to Restrict His Availability to Investors 2China Sky One Medical's Chief Financial Officer's Health Issues to Restrict His Availability to Investors 3Jiangchuan Macrolide Facility Update 2Jiangchuan Macrolide Facility Update 3Jiangchuan Macrolide Facility Update 4
(Date:10/22/2014)... On Saturday, October 25, 2014, the Brownsville Community Health ... fitness fair ¡Vive tu vida! Get Up! Get Moving!®. The ... better health and wellness for people of all ages and ... the public, will be held at Dean Porter Park, 501 ... pm. , “¡Vive tu Vida! Get Up! Get Moving!® ...
(Date:10/22/2014)... For Dr. Iris Hunter, a job is ... extension of her life’s mission. Her extensive experience in the ... of FirstLight HomeCare, make it clear that Hunter’s mission is ... my work makes a difference in the lives of others,” ... after much research, I felt ready to start on this ...
(Date:10/22/2014)... Va. (PRWEB) October 22, 2014 ... Innovation , which is dedicated to distribute health ... of healthcare delivery worldwide announced the development of ... which patients expect when receiving healthcare. These are ... for patient-centered care: “providing care that is respectful ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the most distinguished ... announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the best ... world. , “iPower is one of the most reliable ... kinds of useful products for new and old clients. ... service and a number of features which will appeal ...
(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
Breaking Medicine News(10 mins):Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2
... the poor less likely to receive sentinel lymph node biopsy, ... The use of a less invasive form of sentinel lymph ... the United States from 1998 to 2005, researchers say. However, ... the therapy. , A team at Emory University found ...
... 25 D.I.S.C. Spine and,Sports Center, proudly ... an initial 18 months of operation where ... Dr. Robert S. Bray Jr., founding director ... fully-integrated medical group,providing next generation diagnostics, conservative ...
... WASHINGTON, March 25 It,s the time of year when ... warm climates to,soak up the sun and drink large quantities ... almost three times as much as,those who stay home with ... issue of the Journal of Studies on Alcohol and Drugs., ...
... March 25 Plexus Systems, Inc. and,the ... efficient manufacturing,operations on Thursday, March 27 at ... Smart Manufacturing! Manufacturing IQ & Manufacturing,Operations Management, ... best practices to achieve quality and efficiency ...
... An increased number of neuron hubs in the epileptic ... characterize the disorder, according to a UC Irvine study. , ... Anatomy and Neurobiology identified that these hubs a small ... hippocampus during the transition from a healthy brain to an ...
... Pharmaceuticals Inc. today,announced the appointment of Anthony "Tony" ... the recently initiated Phase 2 clinical trial of,CTS-1027 ... assisting in the,development of the longer-term clinical development ... more than 20 years in the,industry. Previous industrial ...
Cached Medicine News:Health News:Gaps Persist in Use of Less Invasive Breast Cancer Procedure 2Health News:Zero Patient Infections Reported as D.I.S.C. Spine and Sports Center Sets New Standard for Specialty Hospitals 2Health News:It's Spring Break: How Much Does Heavy Drinking Affect Your Body? 2Health News:Plexus Systems, Inc. and Aberdeen Group Co-host March 27 Webinar on Manufacturing Efficiency 2Health News:Plexus Systems, Inc. and Aberdeen Group Co-host March 27 Webinar on Manufacturing Efficiency 3Health News:Epilepsy marked by neural 'hub' network 2Health News:Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer 2
... IMMULITE and IMMULITE 1000 ... with the IMMULITE and IMMULITE ... analyzers which offer simplicity in ... systems can be found in ...
... Anti-Nuclear Antibodies (ANAs) has long been an ... rheumatic diseases. The antigens used in their ... of human or animal nuclei, this has ... Antigens (ENAs). The most commonly measured ENA ...
... Automation, Inc. (DAI) ENA Profile Enzyme-Linked Immunosorbent ... of antibodies in human serum to individually ... Scl-70 and Jo-1 in a single serum ... to be used as an aid in ...
... Enzyme-linked immunosorbent assays for the ... antibodies to extractable nuclear antigens ... Antibodies to Sm aid in ... erythematosus (SLE). ,RNP antibodies aid ...
Medicine Products: